Latest filing published 14 Jul 2026 for The Oncology Institute, Inc., €129k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Yale Podnos appears in our data through filings on Starling Oncology, Inc. shares, published by SEC (Form 4). We count 2 filings; the first trade dates from 8 June 2026 and the latest from 14 July 2026.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 14 July 2026, reports a transaction of €129k in Starling Oncology, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations